Takeda Pharmaceutical Files 6-K Report
Ticker: TKPHF · Form: 6-K · Filed: Mar 13, 2025 · CIK: 1395064
| Field | Detail |
|---|---|
| Company | Takeda Pharmaceutical Co Ltd (TKPHF) |
| Form Type | 6-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Takeda filed a 6-K on 3/13/25, confirming Tokyo HQ and SEC file #001-38757.
AI Summary
Takeda Pharmaceutical Company Limited filed a Form 6-K on March 13, 2025, reporting as a foreign private issuer for the month of March 2025. The filing confirms Takeda's principal executive offices are located at 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan. Takeda is registered with the SEC under file number 001-38757 and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides routine updates on Takeda's status as a foreign private issuer, which is important for investors tracking regulatory compliance and corporate information.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would typically indicate significant risk.
Key Numbers
- 001-38757 — SEC File Number (Identifies Takeda's registration with the SEC.)
Key Players & Entities
- Takeda Pharmaceutical Company Limited (company) — Registrant
- 001-38757 (company) — SEC File Number
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8668 Japan (company) — Principal Executive Offices Address
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have distributed or are required to distribute to their security holders.
When was this Form 6-K filed?
This Form 6-K was filed on March 13, 2025.
What is Takeda Pharmaceutical Company Limited's SEC file number?
Takeda Pharmaceutical Company Limited's SEC file number is 001-38757.
Where are Takeda's principal executive offices located?
Takeda's principal executive offices are located at 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan.
Does Takeda file its annual reports under Form 20-F or 40-F?
Takeda indicates it files its annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 13, 2025 regarding TAKEDA PHARMACEUTICAL CO LTD (TKPHF).